In this Diabetes in Real Life column, Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Mary-Elizabeth Patti, MD, and ...

Dr. Jaclyn Smeaton, ND   A clinical review of the landmark renaming of PCOS to PMOS and why this shift reframes the condition ...

In a large cohort study, patients with low-risk pancreatic cystic lesions had a pancreatic cancer incidence of 1.89 per 1000 person-years — 14 times higher than the general population. Many diagnoses ...

Amplified Sciences, a clinical-stage diagnostics company pioneering next-generation multi-omic assays, today announced a new ...

Catching pancreatic cancer early can increase the five-year survival rate from 15% to 80%. Patients with pancreatic cysts, frequently detected during unrelated abdominal CT or MRI imaging, can develop ...

Pancreatic cancer (PC) is the worst prognosis cancer globally, with just 13% of patients who are diagnosed with PC surviving for 5 years or more after initial diagnosis. Early detection of PC is the ...

Mass General Brigham study of more than 6,000 patients highlights the need for long-term personalized surveillance strategies Catching pancreatic cancer early can increase the five-year survival rate ...

A newly developed targeted radiopharmaceutical treatment can effectively slow tumor growth in pancreatic ductal adenocarcinoma (PDAC), according to new research published in the May issue of The ...

A new drug for pancreatic cancer is showing promise in early testing. Daraxonrasib is a daily pill designed to block cancer signals linked to the RAS gene. It has now finished an early-stage clinical ...

JACKSONVILLE, Fla. – It is poised to revolutionize cancer treatment. An experimental drug that targets pancreatic cancer is being fast tracked for approval by the FDA. How promising is this drug’s ...